1. Adoptive Immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2;Chang;J Clin Oncol,1997
2. Generation of vaccine-primed lymphocytes for the treatment of head and neck cancer;Chang;Head and Neck,2003
3. Phase II trial of autologous tumor vaccination, Anti-CD3-activated vaccine-primed lymphocytes, and Interleukin-2 in stage IV renal cell cancer;Chang;J Clin Oncol,2003
4. Generation from tumor-bearing mice of lymphoid cells with in vivo therapeutic efficacy;Shu;J Immunol,1987
5. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization: Culture requirements and characterization of immunologic specificity;Chou;J Immunol,1988